Replimune Group Inc buy BMO Capital Markets
Start price
22.11.24
/
50%
€15.40
Target price
22.11.25
€17.31
Performance (%)
-49.03%
End price
23.11.25
€7.85
Summary
This prediction ended on 23.11.25 with a price of €7.85. The BUY prediction by BMO_Capital_Markets for Replimune Group Inc performed very badly with a performance of -49.03%. BMO_Capital_Markets has a follow-up prediction for Replimune Group Inc where he still thinks Replimune Group Inc is a Buy. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Replimune Group Inc | -4.861% | -4.861% | -34.762% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% |
Comments by BMO_Capital_Markets for this prediction
In the thread Replimune Group Inc diskutieren
Replimune Group, Inc. (NASDAQ: REPL) had its price target raised by analysts at BMO Capital Markets from $14.00 to $18.00. They now have an "outperform" rating on the stock.
Ratings data for REPL provided by MarketBeat
In the thread Trading Replimune Group Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Replimune Group Inc
Replimune Group Inc
Start price
Target price
Perf. (%)
€12.90
22.01.25
22.01.25
€25.92
22.01.26
22.01.26
-47.67%
07:38
07:38
